# Needle-based Percutaneous Ablation of Liver Tumors.

> **NCT06689670** · NA · RECRUITING · sponsor: **inTumo Therapeutics, Inc.** · enrollment: 31 (estimated)

## Conditions studied

- Liver Tumors
- HCC - Hepatocellular Carcinoma
- Metastatic Liver Tumor

## Interventions

- **DEVICE:** Needle based delivery of INT001 into liver tumors under real-time image guidance

## Key facts

- **NCT ID:** NCT06689670
- **Lead sponsor:** inTumo Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-28
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 31 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06689670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06689670, "Needle-based Percutaneous Ablation of Liver Tumors.". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06689670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*